|
Galactosemia Newborn
Screening Results Protocol Missouri screens newborn for galactosemia by measuring the activity of the enzyme, galactose-1-phosphate uridyl transferase (also known as GALT). This enzyme is responsible converting galactose-1-phosphate into glucose-1-phosphate. Deficiency of this enzyme causes elevations of galactose-1-phosphate and hence the symptoms of galactosemia. Because Missouri does not measure galactose-1-phosphate level, screening for galactokinase or epimerase deficiency is not performed on Missouri newborns. For questions about follow-up testing for an abnormal galactosemia screen, please contact Dawn Peck at 573-884-5192. To download a fact sheet about galactosemia, click here. To download a follow-up protocol for an abnormal galactosemia screen, click here.
University Children’s
Genetics Lab (Progene)
Mayo Clinic Biochemical
Genetics Lab
Children’s Mercy Molecular
Genetics Lab
Division of Medical Genetics |